Use of the Chi-Square Test to Determine Significance of Cumulative Antibiogram Data. Use of the Chi-Square Test to Determine Significance of Cumulative Antibiogram Data.

Use of the Chi-Square Test to Determine Significance of Cumulative Antibiogram Data‪.‬

American Journal of Infectious Diseases 2005, Oct, 1, 4

    • $5.99
    • $5.99

Publisher Description

Abstract: An important function of a hospital's Infectious Disease and Pharmacy programs is to review and compare the most recent antibiogram with that of the previous year to determine if significant changes in antibiotic susceptibility results are noted and to communicate this information and its consequences to the medical staff. However, there are currently no formal analytical (decision-making) models in use to determine if the rate of resistance to an antibiotic from one year to the next has significantly changed more or less than one would expect due to sampling error and test reliability. The purpose of this article, therefore, is to demonstrate the utility of using a well-established and simple nonparametric statistical technique (chi-square) for analyzing annual variations in cumulative antibiogram data and to determine whether such variations are significantly different from chance and to what to degree. The chi-square model outlined here is a simple, practical, quick, low burden and easy to understand and execute approach that greatly improves the analysis of antibiogram data and decisionmaking by practitioners. More work and research is needed to develop additional inferential statistical methods and models that can be applied to antibiogram data. Key words: Antibiogram, chi-square, decision-making, nonparametric, statistic

GENRE
Science & Nature
RELEASED
2005
October 1
LANGUAGE
EN
English
LENGTH
18
Pages
PUBLISHER
Science Publications
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
187
KB
Design and Analysis of Clinical Trials Design and Analysis of Clinical Trials
2013
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Practical Biostatistics Practical Biostatistics
2021
Statistical Issues in Drug Research and Development Statistical Issues in Drug Research and Development
2017
Applied Statistics for Medicine Applied Statistics for Medicine
2011
Intelligence and Security Informatics: Biosurveillance Intelligence and Security Informatics: Biosurveillance
2007
Medical Consequences of Drug Abuse and Co-Occurring Infections: A Brief Review (Clinical Report) Medical Consequences of Drug Abuse and Co-Occurring Infections: A Brief Review (Clinical Report)
2007
Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications. Leptin and Adiponectin in the HIV Associated Metabolic Syndrome: Physiologic and Therapeutic Implications.
2006
Cognitive-Behavioral Stress Management Interventions for Ethnic-Minority Hiv-Positive Alcohol/Drug Abusers in Resource Limited and Culturally Diverse Communities (Human Immunodeficiency Virus) (Report) Cognitive-Behavioral Stress Management Interventions for Ethnic-Minority Hiv-Positive Alcohol/Drug Abusers in Resource Limited and Culturally Diverse Communities (Human Immunodeficiency Virus) (Report)
2009
The Effect of Zinc and "Health Belief Model" Based Education on Common Cold Prevention in Soldiers. The Effect of Zinc and "Health Belief Model" Based Education on Common Cold Prevention in Soldiers.
2006
A Contemporary Analysis of Sexual Trends and Transmitted Infections Among Outpatient at Two Public Hospitals in Jamaica (Report) A Contemporary Analysis of Sexual Trends and Transmitted Infections Among Outpatient at Two Public Hospitals in Jamaica (Report)
2008
Detection of Mycoplasma Genitalium and Trichomonas Vaginalis Infections in General Jordanian Patients (Report) Detection of Mycoplasma Genitalium and Trichomonas Vaginalis Infections in General Jordanian Patients (Report)
2009